Epilepsy, Antiseizure Medications, and Orthodontic Care: A Bibliometric and Thematic Analysis of Craniofacial Development, Oral Health, and Orthodontic Treatment
This bibliometric and thematic analysis of 209 publications reveals that while epilepsy and antiseizure medications significantly impact periodontal health and general oral management, direct evidence regarding their specific effects on orthodontic care and craniofacial development remains critically sparse, highlighting a defined research gap despite biologically plausible mechanisms.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Epilepsy is a condition where the brain's electrical signals fire in unexpected bursts, causing seizures. For many people living with this condition, the solution lies in long-term medication designed to calm those electrical storms. These drugs, known as antiseizure medications, are vital for daily life, but like many powerful medicines, they interact with the rest of the body in complex ways. One of the most well-known side effects involves the mouth. Certain older medications can cause the gums to swell and grow over the teeth, a condition that requires careful dental attention. Beyond the gums, these drugs also influence how bones grow and heal, which is a critical factor for the jaw and the teeth themselves. This biological reality creates a natural question for dentists and orthodontists: if a patient's bones and gums are being altered by their medication, does this change how their teeth should be moved or aligned?
A team of researchers set out to answer this question by looking at the entire history of scientific writing on the subject. They wanted to know if there was a clear, established body of knowledge specifically about moving teeth in people with epilepsy, or if the answer was buried in a sea of unrelated dental research. To find out, they turned to a massive digital library of medical studies called PubMed. They did not just read a few papers; they cast a wide net, gathering thousands of records that mentioned epilepsy, seizures, or the drugs used to treat them alongside any mention of teeth, jaws, or oral health. After removing duplicates and filtering out studies that were only about genetic syndromes rather than the effects of the medication itself, they narrowed their focus to a specific collection of 209 relevant studies published between 1951 and 2026.
The results of this search revealed a striking imbalance in what scientists have chosen to study. The vast majority of the literature, nearly half of all the papers found, focused on the gums and the tissues surrounding the teeth. This makes sense, given the long-standing link between certain medications and gum overgrowth. Another large portion of the research looked at general oral health and how to manage dental care for these patients. However, when the researchers looked specifically for studies about orthodontics—the branch of dentistry that moves teeth to correct alignment and bite—they found very little. Out of the 209 studies in their collection, only five papers directly addressed the question of moving teeth in patients taking these medications. That is less than three percent of the total research.
The few studies that did exist were scattered across time and varied greatly in their design. The earliest was a clinical note from 1981 offering general advice on treating teenagers with epilepsy. A case report from 2012 described a single patient. More recent work included experiments on rats, where scientists applied force to teeth to see how different drugs affected the speed of movement and the health of the bone. Two new studies from 2026 added to this small pile: one looked at a group of human teenagers and found that those on long-term medication seemed to take longer to complete their orthodontic treatment and had slightly different jaw measurements, while the other used a rat model to show that specific drugs changed the molecular signals in the bone during treatment.
Despite these recent additions, the researchers concluded that the evidence is still too thin to change how orthodontists treat patients today. The existing studies suggest that the medications might influence how bone remodels and how teeth move, but the data comes from small groups, animal models, or retrospective reviews rather than large, controlled clinical trials. The authors emphasize that while the biological link is plausible and the gap in knowledge is now clearly defined, there is not yet enough proof to tell doctors to change the force they apply to braces or to predict exactly how long treatment will take based solely on a patient's medication list. The field has mapped the terrain, showing that the path forward requires more focused, high-quality human studies to turn these biological hints into clear clinical guidance.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.